Julie Dewey

Julie Dewey serves as the Chief Investor Relations and Communications Officer at Orthofix Medical Inc. A seasoned executive with more than 25 years of experience in investor relations, corporate communications, and marketing leadership roles, Ms. Dewey has held corporate officer roles for multiple global publicly traded medical device companies. Prior to joining Orthofix, Ms. Dewey served as Chief Communications and Investor Relations Officer at Treace Medical Concepts, Inc., and as Chief Corporate Communications and IR Officer at Nevro Corp. Before that, she was Senior Vice President and Chief Communications Officer at Wright Medical Group, N.V., a leading orthopedics company focused on extremities and biologics that was acquired by Stryker in 2020. Earlier in her career, Ms. Dewey held investor relations and marketing positions at top medical technology companies, including ev3 Inc., Kyphon Inc., and Thoratec Corporation. She holds a BS in Business Administration from the University of Southern California and an MBA from Pepperdine University. Ms. Dewey is a Fellow of the National Investor Relations Institute (NIRI) and holds the Investor Relations Charter (IRC) credential.